(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSTO OU SAL FARMACEUTICAMENTE ACEITÁVEL DO MESMO, RESPECTIVO USO, E COMPOSIÇÃO FARMACÊUTICA

ConcedidaInvention PatentPCT · US2019033896

Application data

Number

112020023866

Type

Invention Patent

Filing

05/24/2019

Publication

04/06/2021

PCT

US2019033896

Progress at the INPI

  1. Filing05/24/19
  2. Publication04/06/21
  3. Examination
  4. Allowance06/09/26
  5. Grant06/23/26
  6. In force05/24/39

The patent was granted on 06/23/2026 and is in force until 05/24/2039. Until then, no one may make, use or sell the invention in Brazil without the owner's authorisation.

Protection valid until:05/24/2039

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 06/23/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

PRIMMUNE THERAPEUTICS, INC.

US

Inventors

J. A. (pessoa física)

US

S. W. (pessoa física)

US

Technical data

Priority claims

US

62/676,433 · 05/25/2018

Abstract

AGONISTAS DE TLR7. A presente invenção refere-se a agonistas de TLR7, de acordo com a Fórmula I e seu uso no tratamento de doenças, tal como câncer e doenças infecciosas.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Concessão da patente

#16.1

Prazo de Validade: 20 (vinte) anos contados a partir de 24/05/2019, observadas as condições legais

06/23/2026

RPI 2894

Deferimento

#9.1

06/09/2026

RPI 2892

Parecer de pré-exame

#6.23

10/31/2023

RPI 2756

Notificação de entrada na fase nacional - PCT

#1.3

04/06/2021

RPI 2622

Alteração de dados cadastrais

#1.1

12/08/2020

RPI 2605

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.